Ionis wins FDA approval of Alexander disease drug zilganersennews2026-09-04T14:46:03+00:00September 4th, 2026|Endpoints News|
FDA leaders project enhanced scrutiny of foreign datanews2026-09-02T19:21:51+00:00September 2nd, 2026|Endpoints News|
CBER official overruled review team’s rejection of new Replimune melanoma drugnews2026-09-02T16:02:32+00:00September 2nd, 2026|Endpoints News|
Three takeaways from Trump’s latest drug pricing eventnews2026-09-01T18:16:50+00:00September 1st, 2026|Endpoints News|
Trump announces nine new MFN drug pricing dealsnews2026-08-31T19:56:17+00:00August 31st, 2026|Endpoints News|
FDA approves Takeda, Protagonist drug for rare blood disordernews2026-08-28T22:15:30+00:00August 28th, 2026|Endpoints News|
Gilead gets another HIV treatment approval, extending lenacapavir’s dominancenews2026-08-27T22:14:58+00:00August 27th, 2026|Endpoints News|
Roivant’s dermatomyositis drug Lisraya snags FDA approvalnews2026-08-27T21:27:19+00:00August 27th, 2026|Endpoints News|
FDA approves Revolution Medicines’ pancreatic cancer drugnews2026-08-26T15:15:20+00:00August 26th, 2026|Endpoints News|
Amgen, academic centers weigh new FDA pilot to speed early drug trialsnews2026-08-25T18:37:14+00:00August 25th, 2026|Endpoints News|
